Gotham Asset Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Buy
64,184
+32,411
+102% +$1.06M 0.01% 1146
2025
Q4
$1.19M Sell
31,773
-7,125
-18% -$234K ﹤0.01% 1209
2025
Q3
$1.07M Sell
38,898
-809
-2% -$27.9K ﹤0.01% 1180
2025
Q2
$1.25M Buy
39,707
+16,544
+71% +$532K 0.01% 1072
2025
Q1
$769K Sell
23,163
-27,339
-54% -$980K 0.01% 1084
2024
Q4
$1.74M Sell
50,502
-16,220
-24% -$557K 0.02% 751
2024
Q3
$2.67M Sell
66,722
-18,283
-22% -$642K 0.03% 653
2024
Q2
$2.56M Buy
85,005
+1,277
+2% +$38.4K 0.03% 610
2024
Q1
$2.81M Buy
83,728
+1,530
+2% +$49.1K 0.04% 545
2023
Q4
$2.65M Buy
82,198
+18,334
+29% +$512K 0.05% 507
2023
Q3
$2.09M Sell
63,864
-8,838
-12% -$307K 0.04% 534
2023
Q2
$2.56M Buy
72,702
+44,969
+162% +$1.55M 0.06% 473
2023
Q1
$905K Buy
+27,733
New +$1.26M 0.02% 781
2022
Q4
Sell
-19,684
Closed -$872K 1255
2022
Q3
$872K Buy
+19,684
New +$960K 0.03% 697

Other funds holding HRMY